Published in Int J Cancer on February 15, 1982
Leukemia inhibitory factor and interleukin-6 trigger the same immediate early response, including tyrosine phosphorylation, upon induction of myeloid leukemia differentiation. Mol Cell Biol (1991) 1.58
Interleukin-6- and leukemia inhibitory factor-induced terminal differentiation of myeloid leukemia cells is blocked at an intermediate stage by constitutive c-myc. Mol Cell Biol (1991) 1.37
The zinc finger transcription factor Egr-1 potentiates macrophage differentiation of hematopoietic cells. Mol Cell Biol (1995) 1.14
Autoregulation of interleukin 6 and granulocyte-macrophage colony-stimulating factor in the differentiation of myeloid leukemic cells. Mol Cell Biol (1989) 0.95
Mechanisms that uncouple growth and differentiation in myeloid leukemia cells: restoration of requirement for normal growth-inducing protein without restoring induction of differentiation-inducing protein. Proc Natl Acad Sci U S A (1982) 0.92
Regulation of cell surface receptors for different hematopoietic growth factors on myeloid leukemic cells. EMBO J (1986) 0.85
DNA-binding protein that induces cell differentiation. EMBO J (1983) 0.78
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature (1991) 9.21
The cloning of normal "mast" cells in tissue culture. J Cell Physiol (1965) 5.47
Interaction of the carbohydrate-binding protein concanavalin A with normal and transformed cells. Proc Natl Acad Sci U S A (1969) 5.39
Characterization of the simian virus 40-specific RNA in virus-yielding and transformed cells. J Mol Biol (1968) 4.65
The induction of cellular DNA synthesis by simian virus 40 in contact-inhibited and in x-irradiated cells. Proc Natl Acad Sci U S A (1966) 4.64
In vitro transformation of normal cells to tumor cells by carcinogenic hydrocarbons. J Natl Cancer Inst (1965) 4.53
In vitro control of the development of macrophage and granulocyte colonies. Proc Natl Acad Sci U S A (1966) 4.13
Structural difference in sites on the surface membrane of normal and transformed cells. Nature (1969) 3.81
The induction of clones of normal mast cells by a substance from conditioned medium. Exp Cell Res (1966) 3.01
Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemia. Nature (1978) 2.97
In vitro cell transformation by x-irradiation. Nature (1966) 2.75
Induction of colony formation in vitro by human lymphocytes. Nature (1976) 2.71
On the mechanism of polyoma virus-induced synthesis of cellular DNA. Proc Natl Acad Sci U S A (1965) 2.67
The zinc finger transcription factor Egr-1 is essential for and restricts differentiation along the macrophage lineage. Cell (1993) 2.55
Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways. Oncogene (1994) 2.49
Destruction of mouse and rat embryo cells in tissue culture by lymph node cells from unsensitized rats. J Cell Physiol (1965) 2.44
Specific inhibition by N-acetyl-D-galactosamine of the interaction between soybean agglutinin and animal cell surfaces. Biochim Biophys Acta (1970) 2.33
Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis. Proc Natl Acad Sci U S A (1990) 2.25
Sequence of MyD116 cDNA: a novel myeloid differentiation primary response gene induced by IL6. Nucleic Acids Res (1990) 2.23
In vitro induction of granulocyte differentiation in hematopoietic cells from leukemic and non-leukemic patients. Proc Natl Acad Sci U S A (1970) 2.22
Regulation of normal differentiation in mouse and human myeloid leukemic cells by phorbol esters and the mechanism of tumor promotion. Proc Natl Acad Sci U S A (1979) 2.17
Cervical competence as a continuum: a study of ultrasonographic cervical length and obstetric performance. Am J Obstet Gynecol (1995) 2.10
Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1. Proc Natl Acad Sci U S A (2001) 2.10
Identification of mutagenic metabolites of benzo(a)pyrene in mammalian cells. Proc Natl Acad Sci U S A (1976) 1.96
Hybridization between SV40 DNA and cellular DNA's. J Mol Biol (1969) 1.92
Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. Blood (1993) 1.90
Cell susceptibility to transformation and cytotoxicity by the carcinogenic hydrocarbon benzo[a]pyrene. Proc Natl Acad Sci U S A (1966) 1.86
Control of lysozyme induction in the differentiation of myeloid leukemic cells. Cell (1976) 1.79
Reversion of properties in cells transformed by polyoma virus. Nature (1968) 1.79
DNA rearrangement of a homeobox gene in myeloid leukaemic cells. EMBO J (1988) 1.75
The continued requirement for inducer for the development of macrophage and granulocyte colonies. J Cell Physiol (1968) 1.67
Genotoxic-stress-response genes and growth-arrest genes. gadd, MyD, and other genes induced by treatments eliciting growth arrest. Ann N Y Acad Sci (1992) 1.66
Receptor mobility and the mechanism of cell-cell binding induced by concanavalin A. Proc Natl Acad Sci U S A (1974) 1.65
An analysis of the mechanism of neoplastic cell transformation by polyoma virus, hydrocarbons, and x-irradiation. Curr Top Dev Biol (1967) 1.64
Differential toxicity on normal and transformed cells in vitro and inhibition of tumour development in vivo by concanavalin A. Nature (1970) 1.64
Chromosome mapping of the genes that control differentiation and malignancy in myeloid leukemic cells. Proc Natl Acad Sci U S A (1977) 1.64
Nucleotide sequence and expression of a cDNA encoding MyD88, a novel myeloid differentiation primary response gene induced by IL6. Oncogene (1990) 1.61
The in vitro induction of an increase in cell multiplication and cellular life span by the water-soluble carcinogen dimethylnitrosamine. Proc Natl Acad Sci U S A (1968) 1.60
The difference in contact inhibition of cell replication between normal cells and cells transformed by different carcinogens. Proc Natl Acad Sci U S A (1966) 1.59
Leukemia inhibitory factor and interleukin-6 trigger the same immediate early response, including tyrosine phosphorylation, upon induction of myeloid leukemia differentiation. Mol Cell Biol (1991) 1.58
Sequence and expression of a cDNA encoding MyD118: a novel myeloid differentiation primary response gene induced by multiple cytokines. Oncogene (1991) 1.55
Regulation by bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemic cells. Cell Growth Differ (1993) 1.50
Ciromosomal control of reversion in transformed cells. Nature (1971) 1.48
Different blocks in the differentiation of myeloid leukemic cells. Proc Natl Acad Sci U S A (1974) 1.47
Mutability of different genetic loci in mammalian cells by metabolically activated carcinogenic polycyclic hydrocarbons. Proc Natl Acad Sci U S A (1976) 1.47
The myeloid blood cell differentiation-inducing protein MGI-2A is interleukin-6. Blood (1988) 1.47
A theory on the mechanism of carcinogenesis by small deoxyribonucleic acid tumour viruses. Nature (1965) 1.45
Deregulated c-myb disrupts interleukin-6- or leukemia inhibitory factor-induced myeloid differentiation prior to c-myc: role in leukemogenesis. Mol Cell Biol (1992) 1.45
Control of the reversion of properties in transformed cells. Nature (1970) 1.44
Complexity of the immediate early response of myeloid cells to terminal differentiation and growth arrest includes ICAM-1, Jun-B and histone variants. Oncogene (1990) 1.44
Interferon regulatory factor 1 is a myeloid differentiation primary response gene induced by interleukin 6 and leukemia inhibitory factor: role in growth inhibition. Cell Growth Differ (1991) 1.43
Control of normal differentiation of myeloid leukemic cells. VIII. Induction of differentiation to mature granulocytes in mass culture. J Cell Physiol (1975) 1.42
Cell susceptibility to transformation by x-irradiation and fixation of the transformed state. Proc Natl Acad Sci U S A (1967) 1.41
Rotational relaxation time of concanavalin A bound to the surface membrane of normal and malignant transformed cells. J Mol Biol (1973) 1.40
Mobility of carbohydrate containing sites on the surface membrane in relation to the control of cell growth. FEBS Lett (1973) 1.39
Regulation of membrane changes, differentiation, and malignancy in carcinogenesis. Harvey Lect (1974) 1.39
[CFS, the condition with the thousands different names. "The tired nomad"--a modern epidemic?]. Lakartidningen (1994) 1.38
Ion metabolism in a Halobacterium. I. Influence of age of culture on intracellular concentrations. J Gen Physiol (1970) 1.38
Mutagenesis and transformation of normal cells by chemical carcinogens. Nature (1976) 1.37
Inhibition of ascites tumor development by concanavalin A. Int J Cancer (1972) 1.36
Control of normal differentiation of myeloid leukemic cells to macrophages and granulocytes. Proc Natl Acad Sci U S A (1973) 1.36
Constitutive uncoupling of pathways of gene expression that control growth and differentiation in myeloid leukemia: a model for the origin and progression of malignancy. Proc Natl Acad Sci U S A (1980) 1.35
Proto-oncogenes of the fos/jun family of transcription factors are positive regulators of myeloid differentiation. Mol Cell Biol (1993) 1.34
Induction of virus synthesis in polyoma transformed cells by ultraviolet light and mitomycin C. Virology (1970) 1.34
Enzymatic hydroxylation of benzopyrene and its relationship to cytotoxicity. Proc Natl Acad Sci U S A (1969) 1.33
Cell-mediated mutagenesis of mammalian cells with chemical carcinogens. Int J Cancer (1974) 1.32
An unusual transposon with long terminal inverted repeats in the sea urchin Strongylocentrotus purpuratus. Nature (1984) 1.32
Genetic dissection of the control of normal differentiation in myeloid leukemic cells. Proc Natl Acad Sci U S A (1977) 1.32
The stimulation of tumor cell growth by a substance produced by normal and tumor cells. J Cell Physiol (1969) 1.30
Formation of bone tissue in culture from isolated bone cells. J Cell Biol (1974) 1.30
The activation of virus synthesis in polyoma-transformed cells. Virology (1969) 1.28
Induction of specific changes in the surface membrane of myeloid leukemic cells by steroid hormones. Int J Cancer (1975) 1.28
Receptor mobility and the binding of cells to lectin-coated fibers. J Cell Biol (1975) 1.27
Papovaviridae. Intervirology (1974) 1.26
Regulation of the induction of colonies in vitro by normal human lymphocytes. Proc Natl Acad Sci U S A (1976) 1.24
The oncogenic potential of an activated Hox-2.4 homeobox gene in mouse fibroblasts. Mol Cell Biol (1991) 1.23
Indirect induction of differentiation in myeloid leukemic cells by lipid A. Proc Natl Acad Sci U S A (1978) 1.23
Identification of the chromosomes that control malignancy. Nat New Biol (1973) 1.22
Control of Fc and C3 receptors on myeloid leukemic cells. J Immunol (1976) 1.20
Differences in the binding of fluorescent concanavalin A to the surface membrane of normal and transformed cells. Proc Natl Acad Sci U S A (1972) 1.20
A specific metabolic activity on the surface membrane in malignant cell-transformation. Proc Natl Acad Sci U S A (1971) 1.19
Characterization of the inducer required for the development of macrophage and granulocyte colonies. Proc Natl Acad Sci U S A (1971) 1.19
Human homologs of TU transposon sequences: polypurine/polypyrimidine sequence elements that can alter DNA conformation in vitro and in vivo. Mol Cell Biol (1986) 1.18
Targeting of N-CoR and histone deacetylase 3 by the oncoprotein v-erbA yields a chromatin infrastructure-dependent transcriptional repression pathway. EMBO J (2000) 1.18
Integration of viral into chromosomal deoxyribonucleic acid in an inducible line of polyoma-transformed cells. Virology (1973) 1.17
The diagnosis of sex before birth using cells from the amniotic fluid (a preliminary report). Bull Res Counc Isr (1955) 1.17
The formation of variants with a reversion of properties of transformed cells. 3. Reversion of the structure of the cell surface membrane. Int J Cancer (1969) 1.17
The meaning of 6.8: numeracy and normality in health information talks. Soc Sci Med (1996) 1.16
Enzymatic hydrolysis of uridine diphosphate-N-acetyl-D-galactosamine and uridine diphosphate-N-acetyl-D-glucosamine by normal cells, and blocks in this hydrolysis in transformed cells and their revertants. J Biol Chem (1972) 1.16
Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor beta 1 and cancer chemotherapy compounds in myeloid leukemic cells. Blood (1992) 1.16
Feedback inhibition of the development of macrophage and granulocyte colonies. I. Inhibition by macrophage. Proc Natl Acad Sci U S A (1967) 1.15
Normal differentiation of myeloid leukaemic cells induced by a differentiation-inducing protein. Nat New Biol (1972) 1.15
Membrane changes associated with malignancy. Nat New Biol (1972) 1.14
Epigenetics and the plasticity of differentiation in normal and cancer stem cells. Oncogene (2006) 1.13
Control of cloning of normal human T lymphocytes by transferrin, albumin and different lectins. Clin Exp Immunol (1978) 1.13
Differential suppression by protease inhibitors and cytokines of apoptosis induced by wild-type p53 and cytotoxic agents. Proc Natl Acad Sci U S A (1996) 1.13
Quantitation of N-acetyl-D-galactosamine-like sites on the surface membrane of normal and transformed mammalian cells. Biochim Biophys Acta (1971) 1.12
Proto-oncogene expression and dissection of the myeloid growth to differentiation developmental cascade. Oncogene (1989) 1.11